GSKvsThermo Fisher Scientific

GSK and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$683.89

Value $254B

-0.18%
TMO's page

GSK (GSK) has a market value of $98.9B and Thermo Fisher Scientific (TMO) $254B. Over the last year, with dividends, GSK moved +6.5% and TMO +21.0%. The P/E is 12.9 for GSK and 35.9 for TMO. Dividend yield: GSK 3.64%, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GSK$98.9B

    TMO$254B

    TMO is 2.6 times GSK

  • Revenue, 12 months

    GSK$43.9B

    TMO$47.4B

    TMO is 1.1 times GSK

  • Net income, 12 months

    GSK$7.7B

    TMO$7.1B

    GSK is 1.1 times TMO

  • Operating margin

    GSK24.3%

    TMO17.9%

    6.4 points apart

  • ROIC

    GSK18.6%

    TMO8.2%

    10.4 points apart

  • P/E

    GSK12.9

    TMO35.9

    TMO is 2.8 times GSK

  • Dividend yield

    GSK3.6%

    TMO0.3%

    3.3 points apart

  • 5-year return

    GSK+42.0%

    TMO+8.9%

    33.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GSK+42.0%

TMO+8.9%

10015020222023202420252026
Returns by period
PeriodGSKWith dividendsTMOWith dividends
1 year since November 17, 2025+6.5%Price +2.8%+21.0%Price +20.6%
3 years since November 17, 2023+55.9%+16.0% a yearPrice +38.9%+48.1%+14.0% a yearPrice +46.6%
5 years since November 17, 2021+42.0%+7.3% a yearPrice +14.9%+8.9%+1.7% a yearPrice +7.3%
10 years since November 18, 2016+103.7%+7.4% a yearPrice +28.3%+382.5%+17.0% a yearPrice +369.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GSKGSKTMOThermo Fisher Scientific

Valuation

GSKTMO
Valuation
Price$48.83$683.89
Market value$98.9B$254B
Enterprise value (EV)$119B$289B
P/E12.935.9
P/E, 5-year median13.132.7
P/B4.64.6
EV/EBIT11.234.2
Free cash flow yield8.7%3.0%

Results and growth

GSKTMO
Results and growth
Revenue, 12 months$43.9B$47.4B
Net income, 12 months$7.7B$7.1B
Free cash flow, 12 months$8.6B$7.6B
Earnings per share, 12 months$3.73$18.96
Revenue growth, year on year4.1%3.9%
Revenue growth a year, past+6.1%over 5 years+6.7%over 5 years
EPS growth a year, past-0.5%over 5 years+2.1%over 5 years

Margins and returns on capital

GSKTMO
Margins and returns on capital
Gross margin72.4%–
Operating margin24.3%17.9%
Net margin17.5%14.9%
ROIC18.6%8.2%
ROE35.8%13.4%

Balance sheet

GSKTMO
Balance sheet
Cash$4.6B$6.1B
Total debt$24.9B$41.4B
Net debt / EBITDA1.53.7
Interest cover–5.5×

Dividends and buybacks

GSKTMO
Dividends and buybacks
Dividend yield3.6%0.3%
Dividend per share, 12 months$1.78$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield1.9%1.2%
Shareholder yield5.5%1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GSK or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, GSK or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($254B) is about 2.6 times GSK ($98.9B), at today's prices.

How did GSK and TMO stock do over the last 10 years?

Since November 18, 2016, GSK's price moved +28.3% and TMO's +369.0%. With dividends: GSK +103.7% (+7.4% a year), TMO +382.5% (+17.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, GSK or TMO?

The dividend yield at today's price is 3.64% for GSK and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid $1.78 and $1.84 per share.

What is the P/E of GSK and TMO?

At today's price, the P/E is 12.9 for GSK and 35.9 for TMO. The median of the last five years was 13.1 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, GSK or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 17.5% for GSK and 14.9% for Thermo Fisher Scientific, and the operating margin 24.3% and 17.9%. Revenue was $43.9B and $47.4B.

Which is the better investment, GSK or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.